$RLFTF (opinion) by Priviledged on Yh0 - After rea
Post# of 653
(Total Views: 298)
Posted On: 05/28/2021 12:48:39 AM
$RLFTF (opinion) by Priviledged on Yh0 - After reading posts by others that "Relief missed the Covid opportunity" I am motivated to make a comment. Sure, had we been approved in the spring of last year, our share value would be tracking the other direction.
But what could we have done differently? We have clinical trials for a reason and there are companies such as CYDY who will definitely attempt to manipulate trial results to gain passage via the FDA. Those of us who believe in the science behind Aviptadil have been blown away by delay after delay, especially after seeing early miraculous results.
So why do you think the FDA is spending tons of money and resources all over the world to find therapeutics that will combat this virus? Perhaps they expect we have not seen the last of Covid 19 or other transmissible viruses that attack the lungs. Remember, there is still a great deal of speculation of the origins of this virus and the expectations of future variants.
Not only do scientists have to anticipate on how to fight Covid with vaccines in the future, but they need a go to cure, if the vaccines become ineffective to future variants. After considering all that we face in regards to SARS related illness, among other potential treatments that our drug may be used for, I still believe strongly in our investment.
Apparently institutions are still believing as well considering we are not seeing massive sellouts. Continue to track the institutional money. Good news is coming our way.
But what could we have done differently? We have clinical trials for a reason and there are companies such as CYDY who will definitely attempt to manipulate trial results to gain passage via the FDA. Those of us who believe in the science behind Aviptadil have been blown away by delay after delay, especially after seeing early miraculous results.
So why do you think the FDA is spending tons of money and resources all over the world to find therapeutics that will combat this virus? Perhaps they expect we have not seen the last of Covid 19 or other transmissible viruses that attack the lungs. Remember, there is still a great deal of speculation of the origins of this virus and the expectations of future variants.
Not only do scientists have to anticipate on how to fight Covid with vaccines in the future, but they need a go to cure, if the vaccines become ineffective to future variants. After considering all that we face in regards to SARS related illness, among other potential treatments that our drug may be used for, I still believe strongly in our investment.
Apparently institutions are still believing as well considering we are not seeing massive sellouts. Continue to track the institutional money. Good news is coming our way.
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ